Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
|
|
Apexigen, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/25/2023 |
4
| Zabrowksi Dan (Director) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Disposed/sold 100,000 options to buy
@ $2.65, valued at
$265k
|
|
| 08/25/2023 |
4
| Wertheimer Samuel P (Director) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Disposed/sold 146,383 shares
@ $0
Disposed/sold 100,000 options to buy
@ $2.65, valued at
$265k
Disposed/sold 12,383 warrants
@ $11.5, valued at
$142.4k
Disposed/sold 1,845 warrants
@ $1.75, valued at
$3.2k
|
|
| 08/25/2023 |
4
| Smith Scott Andrew (Director) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Disposed/sold 34,084 options to buy
@ $6.94, valued at
$236.5k
Disposed/sold 100,000 options to buy
@ $2.65, valued at
$265k
|
|
| 08/25/2023 |
4
| RINGOLD GORDON (Director) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Disposed/sold 10,000 shares
@ $0
Disposed/sold 34,084 options to buy
@ $4.59, valued at
$156.4k
Disposed/sold 100,000 options to buy
@ $2.65, valued at
$265k
Disposed/sold 5,000 warrants
@ $11.5, valued at
$57.5k
|
|
| 08/25/2023 |
4
| Chhabra Meenu (Director) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Disposed/sold 100,000 options to buy
@ $2.65, valued at
$265k
|
|
| 08/25/2023 |
4
| Dupont Jakob (Director) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Disposed/sold 34,084 options to buy
@ $4.59, valued at
$156.4k
Disposed/sold 20,489 options to buy
@ $0
Disposed/sold 100,000 options to buy
@ $2.65, valued at
$265k
|
|
| 08/25/2023 |
4
| CROSS HERB (Director) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Disposed/sold 34,084 options to buy
@ $6.94, valued at
$236.5k
Disposed/sold 100,000 options to buy
@ $2.65, valued at
$265k
|
|
| 08/25/2023 |
4
| Wong Amy (SVP, Finance and Operations) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Paid exercise price by delivering 15,561 shares
@ $0.3851, valued at
$6k
Disposed/sold 66,565 shares
@ $0
Disposed/sold 22,333 options to buy
@ $1.27, valued at
$28.4k
Disposed/sold 8,708 options to buy
@ $1.47, valued at
$12.8k
Disposed/sold 230,507 options to buy
@ $1.66, valued at
$382.6k
Disposed/sold 15,367 options to buy
@ $2.25, valued at
$34.6k
Disposed/sold 13,830 options to buy
@ $2.25, valued at
$31.1k
Disposed/sold 71,159 options to buy
@ $3.62, valued at
$257.6k
Disposed/sold 28,685 options to buy
@ $4.59, valued at
$131.7k
Disposed/sold 25,611 options to buy
@ $4.59, valued at
$117.6k
Disposed/sold 15,366 options to buy
@ $4.59, valued at
$70.5k
|
|
| 08/25/2023 |
4
| Sarena Francis Willard (President and COO) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Paid exercise price by delivering 31,123 shares
@ $0.3851, valued at
$12k
Disposed/sold 124,296 shares
@ $0
Disposed/sold 269,847 options to buy
@ $4.79, valued at
$1.3M
|
|
| 08/25/2023 |
4
| Hsu Frank J. (Chief Medical Officer) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Disposed/sold 16,354 shares
@ $0
Disposed/sold 224,872 options to buy
@ $4.79, valued at
$1.1M
Disposed/sold 27,000 options to buy
@ $2.46, valued at
$66.4k
|
|
| 08/25/2023 |
4
| Duke William E. (CFO) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Paid exercise price by delivering 26,416 shares
@ $0.3851, valued at
$10.2k
Disposed/sold 128,001 shares
@ $0
Disposed/sold 269,848 options to buy
@ $2.46, valued at
$663.8k
|
|
| 08/25/2023 |
4
| Yang Xiaodong (CEO) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Granted 400,000 shares
@ $0
Paid exercise price by delivering 69,161 shares
@ $0.3851, valued at
$26.6k
Disposed/sold 863,729 shares
@ $0
Disposed/sold 219,950 options to buy
@ $1.27, valued at
$279.3k
Disposed/sold 20,489 options to buy
@ $1.47, valued at
$30.1k
Disposed/sold 461,015 options to buy
@ $1.66, valued at
$765.3k
Disposed/sold 35,856 options to buy
@ $2.25, valued at
$80.7k
Disposed/sold 30,734 options to buy
@ $2.25, valued at
$69.2k
Disposed/sold 295,978 options to buy
@ $3.62, valued at
$1.1M
Disposed/sold 99,373 options to buy
@ $6.54, valued at
$649.9k
Disposed/sold 12,296 options to buy
@ $7.03, valued at
$86.4k
|
|
| 08/24/2023 |
3/A
| Dupont Jakob (Director) has filed a Form 3/A on Apexigen, Inc. |
| 05/25/2023 |
4
| Wong Amy (SVP, Finance and Operations) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Granted 75,000 shares
@ $0
Paid exercise price by delivering 12,234 shares
@ $0.4, valued at
$4.9k
|
|
| 05/25/2023 |
4
| Duke William E. (CFO) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Granted 150,000 shares
@ $0
Paid exercise price by delivering 17,261 shares
@ $0.4, valued at
$6.9k
|
|
| 05/25/2023 |
4
| Sarena Francis Willard (President and COO) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Granted 150,000 shares
@ $0
Paid exercise price by delivering 20,748 shares
@ $0.4, valued at
$8.3k
|
|
| 05/23/2023 |
4
| Wertheimer Samuel P (Director) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Acquired 146,383 shares
@ $0
Acquired 12,383 warrants
@ $11.5, valued at
$142.4k
Acquired 1,845 warrants
@ $1.75, valued at
$3.2k
|
|
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Sarena Francis Willard (COO) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Paid exercise price by delivering 6,916 shares
@ $1.06, valued at
$7.3k
|
|
| 12/19/2022 |
4
| Hsu Frank J. (Chief Medical Officer) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Paid exercise price by delivering 4,323 shares
@ $1.06, valued at
$4.6k
|
|
| 12/19/2022 |
4
| Duke William E. (CFO) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Paid exercise price by delivering 4,503 shares
@ $1.06, valued at
$4.8k
|
|
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2022 |
4
| Wong Amy (SVP, Finance and Operations) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Granted 16,488 shares
@ $0
Granted 76,800 options to buy
@ $2.46, valued at
$188.9k
|
|
| 10/11/2022 |
4
| Sarena Francis Willard (COO) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Granted 40,000 shares
@ $0 |
|
| 10/11/2022 |
4
| Hsu Frank J. (Chief Medical Officer) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Granted 25,000 shares
@ $0
Granted 27,000 options to buy
@ $2.46, valued at
$66.4k
|
|
| 10/11/2022 |
4
| Duke William E. (CFO) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Granted 30,685 shares
@ $0
Granted 269,848 options to buy
@ $2.46, valued at
$663.8k
|
|
| 10/11/2022 |
4
| Yang Xiaodong (CEO) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Granted 40,488 shares
@ $0
Granted 305,000 options to buy
@ $2.46, valued at
$750.3k
|
|
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Wertheimer Samuel P (Director) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Granted 100,000 options to buy
@ $2.65, valued at
$265k
|
|
| 10/03/2022 |
4
| Smith Scott Andrew (Director) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Granted 100,000 options to buy
@ $2.65, valued at
$265k
|
|
| 10/03/2022 |
4
| RINGOLD GORDON (Director) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Granted 100,000 options to buy
@ $2.65, valued at
$265k
|
|
| 10/03/2022 |
4
| Chhabra Meenu (Director) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Granted 100,000 options to buy
@ $2.65, valued at
$265k
|
|
| 10/03/2022 |
4
| Dupont Jakob (Director) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Granted 100,000 options to buy
@ $2.65, valued at
$265k
|
|
| 10/03/2022 |
4
| CROSS HERB (Director) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Granted 100,000 options to buy
@ $2.65, valued at
$265k
|
|
|
|
|